{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:37:15Z","timestamp":1792773435511,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032559","name":"Breakthrough T1D","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032559","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020098","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["875534"],"award-info":[{"award-number":["875534"]}],"id":[{"id":"10.13039\/100020098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031584","name":"Deutsches Zentrum f\u00fcr Diabetesforschung","doi-asserted-by":"publisher","award":["82DZD14H03"],"award-info":[{"award-number":["82DZD14H03"]}],"id":[{"id":"10.13039\/100031584","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.lanepe.2026.101806","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T17:44:47Z","timestamp":1786211087000},"page":"101806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Weight and HbA1c trajectories following initiation of continuous glucose monitoring in adults with type 1 diabetes: a cohort study using group-based multi-trajectory analysis"],"prefix":"10.1016","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8579-6914","authenticated-orcid":false,"given":"Sofia","family":"Pazmino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nele","family":"Steenackers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricarda","family":"Sandig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar","family":"van Laar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8663-3723","authenticated-orcid":false,"given":"Jantje","family":"Weiskorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6007-6715","authenticated-orcid":false,"given":"Jolien","family":"De Meulemeester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7854-4233","authenticated-orcid":false,"given":"Julia K.","family":"Mader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Charleer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Wosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja S.C.","family":"Gollisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Erath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"De Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Hurtado del Pozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5521-5445","authenticated-orcid":false,"given":"Carel W.","family":"le Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Nobels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4055-5233","authenticated-orcid":false,"given":"Chantal","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9111-4561","authenticated-orcid":false,"given":"Pieter","family":"Gillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Lanzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4754-784X","authenticated-orcid":false,"given":"Bart","family":"Van der Schueren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Prinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.lanepe.2026.101806_bib1","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41574-021-00542-w","article-title":"One hundred years of insulin therapy","volume":"17","author":"Mathieu","year":"2021","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101806_bib2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s43856-023-00358-x","article-title":"Utility and precision evidence of technology in the treatment of type 1 diabetes: a systematic review","volume":"3","author":"Jacobsen","year":"2023","journal-title":"Commun Med"},{"issue":"7","key":"10.1016\/j.lanepe.2026.101806_bib3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2337\/diacare.11.7.567","article-title":"Weight gain associated with intensive therapy in the diabetes control and complications trial. The DCCT Research Group","volume":"11","year":"1988","journal-title":"Diabetes Care"},{"issue":"6554","key":"10.1016\/j.lanepe.2026.101806_bib4","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1126\/science.abg4502","article-title":"Type 1 diabetes glycemic management: insulin therapy, glucose monitoring, and automation","volume":"373","author":"Perkins","year":"2021","journal-title":"Science"},{"issue":"14","key":"10.1016\/j.lanepe.2026.101806_bib5","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJMoa0805017","article-title":"Continuous glucose monitoring and intensive treatment of type 1 diabetes","volume":"359","author":"Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group","year":"2008","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.lanepe.2026.101806_bib6","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S2213-8587(16)30193-0","article-title":"Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial","volume":"4","author":"van Beers","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10128","key":"10.1016\/j.lanepe.2026.101806_bib7","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(18)30297-6","article-title":"Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial","volume":"391","author":"Heinemann","year":"2018","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.lanepe.2026.101806_bib8","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/jama.2016.19975","article-title":"Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial","volume":"317","author":"Beck","year":"2017","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.lanepe.2026.101806_bib9","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/ki.1995.236","article-title":"Effect of intensive therapy on the development and progression of diabetic nephropathy in the diabetes control and complications trial. The diabetes control and complications (DCCT) research group","volume":"47","year":"1995","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.lanepe.2026.101806_bib10","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2337\/dc18-2308","article-title":"Risk factors for retinopathy in type 1 diabetes: the DCCT\/EDIC study","volume":"42","author":"Hainsworth","year":"2019","journal-title":"Diabetes Care"},{"issue":"25","key":"10.1016\/j.lanepe.2026.101806_bib11","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.lanepe.2026.101806_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2025.109089","article-title":"Real-world initiation of continuous glucose monitoring (CGM) in adults with type 1 diabetes leads to increased body mass index - a brief report from IMI-SOPHIA study","volume":"39","author":"Soto-Hernaez","year":"2025","journal-title":"J Diabetes Complications"},{"issue":"10","key":"10.1016\/j.lanepe.2026.101806_bib13","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.2337\/diacare.24.10.1711","article-title":"Influence of intensive diabetes treatment on body weight and composition of adults with type 1 diabetes in the diabetes control and complications trial","volume":"24","author":"Group","year":"2001","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.lanepe.2026.101806_bib14","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2337\/diacare.13.11.1106","article-title":"Weight gain associated with improved glycemic control in population-based sample of subjects with type I diabetes","volume":"13","author":"Wing","year":"1990","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.lanepe.2026.101806_bib15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1089\/dia.2023.0389","article-title":"Weight gain and glycemic control in adults with type 1 diabetes in the T1D exchange registry","volume":"26","author":"Bailey","year":"2024","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"10.1016\/j.lanepe.2026.101806_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/cob.12645","article-title":"The double burden: navigating type 1 diabetes and obesity","volume":"14","author":"Steenackers","year":"2024","journal-title":"Clin Obes"},{"issue":"11","key":"10.1016\/j.lanepe.2026.101806_bib17","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S2213-8587(21)00246-1","article-title":"Obesity in people living with type 1 diabetes","volume":"9","author":"Van der Schueren","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"10.1016\/j.lanepe.2026.101806_bib18","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1089\/dia.2022.0063","article-title":"Dynamics of hemoglobin A1c, body mass index, and rates of severe hypoglycemia in 4434 adults with type 1 or type 2 diabetes after initiation of continuous glucose monitoring","volume":"24","author":"Lanzinger","year":"2022","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"10.1016\/j.lanepe.2026.101806_bib19","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41574-018-0044-y","article-title":"Technology in the management of type 1 diabetes mellitus \u2014 current status and future prospects","volume":"14","author":"Tauschmann","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10.1016\/j.lanepe.2026.101806_bib20","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2337\/dc19-1610","article-title":"Quality of life and glucose control after 1 year of nationwide reimbursement of intermittently scanned continuous glucose monitoring in adults living with type 1 diabetes (FUTURE): a prospective observational real-world cohort study","volume":"43","author":"Charleer","year":"2020","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.lanepe.2026.101806_bib21","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1210\/jc.2017-02498","article-title":"Effect of continuous glucose monitoring on glycemic control, acute admissions, and quality of life: a real-world study","volume":"103","author":"Charleer","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.lanepe.2026.101806_bib22","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1177\/0962280216673085","article-title":"Group-based multi-trajectory modeling","volume":"27","author":"Nagin","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.lanepe.2026.101806_bib23","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.2147\/CLEP.S265287","article-title":"Trajectory modelling techniques useful to epidemiological research: a comparative narrative review of approaches","volume":"12","author":"Nguena Nguefack","year":"2020","journal-title":"Clin Epidemiol"},{"issue":"6","key":"10.1016\/j.lanepe.2026.101806_bib24","doi-asserted-by":"crossref","DOI":"10.1177\/14791641211062155","article-title":"Use of continuous glucose monitoring trend arrows in the younger population with type 1 diabetes","volume":"18","author":"Elbarbary","year":"2021","journal-title":"Diab Vasc Dis Res"},{"issue":"23","key":"10.1016\/j.lanepe.2026.101806_bib25","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1001\/jama.2020.6928","article-title":"Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial","volume":"323","author":"Pratley","year":"2020","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.lanepe.2026.101806_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14528","article-title":"Continuous glucose monitoring: a review of the evidence in type 1 and 2 diabetes mellitus","volume":"38","author":"Lin","year":"2021","journal-title":"Diabet Med"},{"issue":"1","key":"10.1016\/j.lanepe.2026.101806_bib27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/dc20-1468","article-title":"Sustained intensive treatment and long-term effects on HbA(1c) reduction (SILVER study) by CGM in people with type 1 diabetes treated with MDI","volume":"44","author":"Lind","year":"2021","journal-title":"Diabetes Care"},{"issue":"16","key":"10.1016\/j.lanepe.2026.101806_bib28","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa2205650","article-title":"Intermittently scanned continuous glucose monitoring for type 1 diabetes","volume":"387","author":"Leelarathna","year":"2022","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.lanepe.2026.101806_bib29","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S2213-8587(22)00212-1","article-title":"Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study","volume":"10","author":"Choudhary","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"10.1016\/j.lanepe.2026.101806_bib30","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S2213-8587(25)00364-X","article-title":"Tubeless automated insulin delivery versus multiple daily injections in children and adults with type 1 diabetes with elevated HbA(1c) (RADIANT): a multicentre, international, parallel-group, open-label, randomised, controlled trial","volume":"14","author":"Wilmot","year":"2026","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776226002188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776226002188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T15:08:23Z","timestamp":1792768103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666776226002188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":30,"alternative-id":["S2666776226002188"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2026.101806","relation":{},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Weight and HbA1c trajectories following initiation of continuous glucose monitoring in adults with type 1 diabetes: a cohort study using group-based multi-trajectory analysis","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2026.101806","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101806"}}